However , the two agencies will continue to maintain separate approval processes .
In an effort to reduce the burden on manufacturers applying for orphan drug status , the FDA and EMA agreed in late 2007 to utilize a common application process for both agencies .
The two agencies will continue to maintain separate approval processes .
In an effort to reduce the burden on manufacturers applying for orphan drug status , the FDA and EMA agreed in late 2007 to utilize a common application process for both agencies .